Highlights and Quick Summary
- Interest Expense (Operating) for the quarter ending September 30, 2022 was $9 Thousand (a -10.0% decrease compared to previous quarter)
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Interest Expense (Operating) of Benitec Biopharma Limited
Most recent Interest Expense (Operating)of BNTC including historical data for past 10 years.Interactive Chart of Interest Expense (Operating) of Benitec Biopharma Limited
Benitec Biopharma Limited Interest Expense (Operating) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $0.01 | $0.01 | – | – | – |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology